These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3141995)
1. Tumor promotion by a hydroperoxide metabolite of butylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone, in mouse skin. Taffe BG; Kensler TW Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):291-303. PubMed ID: 3141995 [TBL] [Abstract][Full Text] [Related]
2. Quinone methide mediates in vitro induction of ornithine decarboxylase by the tumor promoter butylated hydroxytoluene hydroperoxide. Guyton KZ; Dolan PM; Kensler TW Carcinogenesis; 1994 May; 15(5):817-21. PubMed ID: 8200081 [TBL] [Abstract][Full Text] [Related]
3. Free radical-derived quinone methide mediates skin tumor promotion by butylated hydroxytoluene hydroperoxide: expanded role for electrophiles in multistage carcinogenesis. Guyton KZ; Bhan P; Kuppusamy P; Zweier JL; Trush MA; Kensler TW Proc Natl Acad Sci U S A; 1991 Feb; 88(3):946-50. PubMed ID: 1846971 [TBL] [Abstract][Full Text] [Related]
4. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice. Kruszewski FH; Conti CJ; DiGiovanni J Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733 [TBL] [Abstract][Full Text] [Related]
5. Role of quinone methide in the in vitro toxicity of the skin tumor promoter butylated hydroxytoluene hydroperoxide. Guyton KZ; Thompson JA; Kensler TW Chem Res Toxicol; 1993; 6(5):731-8. PubMed ID: 8292753 [TBL] [Abstract][Full Text] [Related]
6. Generation of reactive intermediates from the tumor promoter butylated hydroxytoluene hydroperoxide in isolated murine keratinocytes or by hematin. Taffe BG; Zweier JL; Pannell LK; Kensler TW Carcinogenesis; 1989 Jul; 10(7):1261-8. PubMed ID: 2472232 [TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion. Guyton KZ; Gorospe M; Kensler TW; Holbrook NJ Cancer Res; 1996 Aug; 56(15):3480-5. PubMed ID: 8758915 [TBL] [Abstract][Full Text] [Related]
8. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
9. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Wei H; Tye L; Bresnick E; Birt DF Cancer Res; 1990 Feb; 50(3):499-502. PubMed ID: 2105157 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related]
13. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin. Bhasin G; Kauser H; Athar M Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284 [TBL] [Abstract][Full Text] [Related]
14. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
15. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
16. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis. Verma AK; Boutwell RK Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of mouse skin tumor promotion by chrysarobin. DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Weekes RG; Verma AK; Boutwell RK Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate. Kozumbo WJ; Seed JL; Kensler TW Cancer Res; 1983 Jun; 43(6):2555-9. PubMed ID: 6850576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]